Global Information
회사소개 | 문의 | 비교리스트

경비 약물전달 기술 시장 분석과 예측 : 치료 용도별(천식, 비염), 제형별(파우더, 젤, 스프레이, 드롭), 용기 종류별

Nasal Drug Delivery Technology Market Analysis Report By Therapeutic Application (Asthma, Rhinitis), By Dosage Form (Powder, Gel, Spray, Drops), By Container Type, And Segment Forecasts, 2019 - 2025

리서치사 Grand View Research, Inc.
발행일 2019년 01월 상품 코드 785999
페이지 정보 영문 90 Pages
가격
US $ 5,950 ₩ 7,292,000 Unprintable PDF by E-mail (Single User License)
US $ 6,950 ₩ 8,518,000 Printable PDF by E-mail (5-User License)
US $ 8,950 ₩ 10,970,000 Printable PDF by E-mail (Enterprise License)


경비 약물전달 기술 시장 분석과 예측 : 치료 용도별(천식, 비염), 제형별(파우더, 젤, 스프레이, 드롭), 용기 종류별 Nasal Drug Delivery Technology Market Analysis Report By Therapeutic Application (Asthma, Rhinitis), By Dosage Form (Powder, Gel, Spray, Drops), By Container Type, And Segment Forecasts, 2019 - 2025
발행일 : 2019년 01월 페이지 정보 : 영문 90 Pages

세계의 경비 약물전달 기술(Nasal Drug Delivery Technology) 시장에 대해 조사했으며, 시장 동향과 부문별 동향, 지역별 예측, 시장에 참여하는 기업 개요에 대해 정리했습니다.

제1장 조사 방법과 조사 범위

제2장 주요 요약

제3장 시장 변수, 동향, 범위

제4장 시장 정의

제5장 업계 전망

  • 시장 변수 분석
  • 시장 성장 저해요인 분석

제6장 비지니스 환경 분석

  • SWOT 분석
  • Porter's Five Forces 분석

제7장 제형별 비지니스 분석

  • 동향 분석
  • 스프레이
  • 드롭
  • 파우더

제8장 용기 종류별 비지니스 분석

  • 동향 분석
  • 가압 용기
  • 비가압 용기

제9장 치료 용도별 비지니스 분석

  • 동향 분석
  • 비폐색
  • 비염
  • 천식
  • 기타

제10장 지역별 비지니스 분석

  • 동향 분석
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

제11장 기업 개요

  • 기업 개요
    • GlaxoSmithkline plc.
    • AstraZeneca
    • Pfizer, Inc.
    • OptiNose
    • Becton, Dickson and Company
    • Promius Pharma
    • B.F. Ascher & Company, Inc.
    • Cadila Pharmaceuticals
    • Douglas NZ
    • ENT Technologies Pty. Ltd.
    • Pendopharm
    • NAVEH Pharma
KSM 19.03.07

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America Nasal Drug Delivery Technology market, by dosage form 2014 - 2025 (USD Billion)
  • Table 3 North America Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
  • Table 4 North America Nasal Drug Delivery Technology market, by therapeutic application 2014 - 2025 (USD Billion)
  • Table 5 U.S. Nasal Drug Delivery Technology market, by dosage types 2014 - 2025 (USD Billion)
  • Table 6 U.S. Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
  • Table 7 U.S. Nasal Drug Delivery Technology market, by therapeutic applications 2014 - 2025 (USD Billion)
  • Table 8 Canada Nasal Drug Delivery Technology market, by dosage forms 2014 - 2025 (USD Billion)
  • Table 9 Canada Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
  • Table 10 Canada Nasal Drug Delivery Technology market, by therapeutic applications 2014 - 2025 (USD Billion)
  • Table 11 Europe Nasal Drug Delivery Technology market, by dosage forms 2014 - 2025 (USD Billion)
  • Table 12 Europe Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
  • Table 13 Europe Nasal Drug Delivery Technology market, by therapeutic applications 2014 - 2025 (USD Billion)
  • Table 14 Germany Nasal Drug Delivery Technology market, by dosage forms 2014 - 2025 (USD Billion)
  • Table 15 Germany Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
  • Table 16 Germany Nasal Drug Delivery Technology market, by therapeutic application 2014 - 2025 (USD Billion)
  • Table 17 U.K. Nasal Drug Delivery Technology market, by dosage forms 2014 - 2025 (USD Billion)
  • Table 18 U.K. Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
  • Table 19 U.K. Nasal Drug Delivery Technology market, by therapeutic application 2014 - 2025 (USD Billion)
  • Table 20 Asia Pacific Nasal Drug Delivery Technology market, by dosage forms 2014 - 2025 (USD Billion)
  • Table 21 Asia Pacific Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
  • Table 22 Asia Pacific Nasal Drug Delivery Technology market, by therapeutic applications 2014 - 2025 (USD Billion)
  • Table 23 Japan Nasal Drug Delivery Technology market, by dosage forms 2014 - 2025 (USD Billion)
  • Table 24 Japan Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
  • Table 25 Japan Nasal Drug Delivery Technology market, by therapeutic applications 2014 - 2025 (USD Billion)
  • Table 26 China Nasal Drug Delivery Technology market, by dosage forms 2014 - 2025 (USD Billion)
  • Table 27 China Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
  • Table 28 China Nasal Drug Delivery Technology market, by therapeutic applications 2014 - 2025 (USD Billion)
  • Table 29 India Nasal Drug Delivery Technology market, by dosage forms 2014 - 2025 (USD Billion)
  • Table 30 India Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
  • Table 31 India Nasal Drug Delivery Technology market, by therapeutic applications 2014 - 2025 (USD Billion)
  • Table 32 Latin America Nasal Drug Delivery Technology market, by dosage forms 2014 - 2025 (USD Billion)
  • Table 33 Latin America Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
  • Table 34 Latin America Nasal Drug Delivery Technology market, by distribution channel 2014 - 2025 (USD Billion)
  • Table 35 Brazil Nasal Drug Delivery Technology market, by dosage forms 2014 - 2025 (USD Billion)
  • Table 36 Brazil Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
  • Table 37 Brazil Nasal Drug Delivery Technology market, by therapeutic applications 2014 - 2025 (USD Billion)
  • Table 38 Mexico Nasal Drug Delivery Technology market, by dosage forms 2014 - 2025 (USD Billion)
  • Table 39 Mexico Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
  • Table 40 Mexico Nasal Drug Delivery Technology market, by therapeutic applications 2014 - 2025 (USD Billion)
  • Table 41 MEA Nasal Drug Delivery Technology market, by dosage forms 2014 - 2025 (USD Billion)
  • Table 42 MEA Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
  • Table 43 MEA Nasal Drug Delivery Technology market, by therapeutic applications 2014 - 2025 (USD Billion)
  • Table 44 South Africa Nasal Drug Delivery Technology market, by dosage forms 2014 - 2025 (USD Billion)
  • Table 45 South Africa Nasal Drug Delivery Technology market, by container type 2014 - 2025 (USD Billion)
  • Table 46 South Africa Nasal Drug Delivery Technology market, by therapeutic applications 2014 - 2025 (USD Billion)

List of Figures

  • Fig.1 Nasal Drug Delivery Technology market, 2017
  • Fig.2 Nasal Drug Delivery Technology market segmentation
  • Fig.3 Nasal Drug Delivery Technology market driver impact
  • Fig.4 Nasal Drug Delivery Technology market driver impact
  • Fig.5 SWOT Analysis, By Factor (Political & legal Economic and technological)
  • Fig.6 Porter's Five Forces Analysis
  • Fig.7 Nasal Drug Delivery Technology market: Dosage form outlook and key takeaways
  • Fig.8 Nasal Drug Delivery Technology market: Dosage Form Movement Analysis
  • Fig.9 Nasal sprays market estimates and forecast, 2014 - 2025
  • Fig.10 Nasal drops market estimates and forecast, 2014 - 2025
  • Fig.11 Nasal gels market estimates and forecast, 2014 - 2025
  • Fig.12 Nasal powder market estimates and forecast, 2014 - 2025
  • Fig.13 Nasal Drug Delivery Technology market: Container type outlook and key takeaways
  • Fig.14 Nasal Drug Delivery Technology market: Container Type Movement Analysis
  • Fig.15 Pressurized containers market estimates and forecast, 2014 - 2025
  • Fig.16 Non-pressurized containers market estimates and forecast, 2014 - 2025
  • Fig.17 Nasal Drug Delivery Technology market: Therapeutic application outlook and key takeaways
  • Fig.18 Nasal Drug Delivery Technology market: Therapeutic Application Movement Analysis
  • Fig.19 Nasal congestion market estimates and forecast, 2014 - 2025
  • Fig.20 Rhinitis market estimates and forecast, 2014 - 2025
  • Fig.21 Asthma market estimates and forecast, 2014 - 2025
  • Fig.22 Others market estimates and forecast, 2014 - 2025
  • Fig.23 Nasal Drug Delivery Technology market: Regional outlook and key takeaways
  • Fig.24 Nasal Drug Delivery Technology market: Regional movement analysis
  • Fig.25 North America
  • Fig.26 North America. market estimates and forecast, 2014 - 2025
  • Fig.27 U.S. market estimates and forecast, 2014 - 2025
  • Fig.28 Canada market estimates and forecast, 2014 - 2025
  • Fig.29 Europe
  • Fig.30 Europe market estimates and forecast, 2014 - 2025
  • Fig.31 Germany market estimates and forecast, 2014 - 2025
  • Fig.32 U.K. market estimates and forecast, 2014 - 2025
  • Fig.33 Asia-Pacific
  • Fig.34 Asia-Pacific market estimates and forecast, 2014 - 2025
  • Fig.35 Japan market estimates and forecast, 2014 - 2025
  • Fig.36 China. market estimates and forecast, 2014 - 2025
  • Fig.37 India market estimates and forecast, 2014 - 2025
  • Fig.38 Latin America
  • Fig.39 Latin America market estimates and forecast, 2014 - 2025
  • Fig.40 Brazil market estimates and forecast, 2014 - 2025
  • Fig.41 Mexico market estimates and forecast, 2014 - 2025
  • Fig.42 Middle East & Africa
  • Fig.43 MEA market estimates and forecast, 2014 - 2025
  • Fig.44 South Africa market estimates and forecast, 2014 - 2025
  • Fig.45 Company profile

The global nasal drug delivery systems market size is expected to reach USD 67.99 billion by 2025 expanding at 6.5% CAGR, according to a new report by Grand View Research, Inc. Rising awareness about nasal products is one of the major factors driving the market. Growing geriatric population is also expected to have positive impact on the market. According to the United Nations Department of Economic and Social Affairs, the global geriatric population (60 years and above), was around 962 million in 2017. The number is expected to grow, particularly in Latin America with 71% rise in population aged 60 and over, followed by Asia (66%), Africa (64%), North America (41%), and Europe (23%).

Moreover, ongoing product development and their expected commercialization will propel market growth over the forecast period. For instance, In April 2018, Dr. Reddy's Laboratories, along with its subsidiary Promius Pharma, LLC, announced filing of their New Drug Application (NDA) for DFN-02, for the treatment of migraine. Increasing adoption of self-administration practices and focus on other alternative routes of drug delivery, such as nasal drug delivery, also offer growth opportunities for the market. Some of the key companies in the industry are AstraZeneca PLC; OptiNose, Inc.; Pfizer, Inc.; Becton, Dickinson and Company; Promius Pharma LLC; B.F. Ascher & Company, Inc.; and Cadila Pharmaceuticals Ltd.

Further key findings from the study suggest:

Nasal sprays led the dosage type segment in 2017 due to increased prevalence of asthma and other infectious diseases

On the other hand, nasal drops segment witnessed the fastest growth in 2017 owing to availability of cost-effective products with better efficacy

Non-pressurized containers segment led the market in 2017 due to continous development in nasal powders and gel products

Asthma was the dominant therapeutic application segment in 2017 and is estimated to be the fastest-growing segment with a CAGR of 7.0% during the forecast years due to increasing disease prevalence

Geographically, North America held the largest share in 2017. Asia Pacific is estimated to witness the fastest CAGR of 7.5% due to presence of key companies, such as Cipla Inc.

Some of the leading companies in the global nasal drug delivery technology market are GlaxoSmithKline PLC; AstraZeneca PLC; Pfizer, Inc.; OptiNose, Inc.; Becton, Dickinson and Company; Promius Pharma, LLC; Cadila Pharmaceuticals Ltd.; B.F. Ascher & Company, Inc.; PendoPharm, Inc.; Douglas Pharmaceuticals Ltd.; ENT Technologies Pty. Ltd.; and NAVEH Pharma Ltd.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Methodology
  • 1.2 Research Scope and Assumptions
  • 1.3 List of Tables

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Segmentation

Chapter 4 Market Definitions

Chapter 5 Industry Outlook

  • 5.1 Market Variable Analysis
    • 5.1.1 Increasing preference for nasal drug delivery technology
    • 5.1.2 Growing incidence of chronic diseases
    • 5.1.3 Growing geriatric population
  • 5.2 Market Restraint Analysis
    • 5.2.1 Complications associated with the overuse of nasal powders

Chapter 6 Business Environment Analysis

  • 6.1 SWOT Analysis; By factor (Political & legal, economic and technological)
  • 6.2 Porter's Five Forces Analysis

Chapter 7 Dosage Forms Business Analysis

  • 7.1 Nasal Drug Delivery Technology market: Dosage Forms Movement Analysis
  • 7.2 Nasal Spray
    • 7.2.1 Nasal sprays market estimates and forecast, 2014 - 2025
  • 7.3 Nasal Drop
    • 7.3.1 Nasal drops market estimates and forecast, 2014 - 2025
  • 7.4 Nasal Gel
    • 7.4.1 Nasal gels market estimates and forecast, 2014 - 2025
  • 7.5 Nasal Powder
    • 7.5.1 Nasal powder market estimates and forecast, 2014 - 2025

Chapter 8 Container Type Business Analysis

  • 8.1 Nasal Drug Delivery Technology market: Container Type Movement Analysis
  • 8.2 Pressurized container
  • 8.3 Pressurized container market estimates and forecast, 2014 - 2025
  • 8.4 Non-pressurized container
  • 8.5 Non-pressurized container market estimates and forecast, 2014 - 2025

Chapter 9 Therapeutic Application Business Analysis

  • 9.1 Nasal Drug Delivery Technology market: Therapeutic Application Movement Analysis
  • 9.2 Nasal Congestion
    • 9.2.1 Nasal congestion market estimates and forecast, 2014 - 2025
  • 9.3 Rhinitis
    • 9.3.1 Rhinitis market estimates and forecast, 2014 - 2025
  • 9.4 Asthma
    • 9.4.1 Asthma market estimates and forecast, 2014 - 2025
  • 9.5 Others
    • 9.5.1 Others market estimates and forecast, 2014 - 2025

Chapter 10 Regional Business Analysis

  • 10.1 Nasal Drug Delivery Technology Market: Regional Movement Analysis
  • 10.2 North America.
    • 10.2.1 North America market estimates and forecast, 2014 - 2025
    • 10.2.2 U.S.
      • 10.2.2.1 U.S. market estimates and forecast, 2014 - 2025
    • 10.2.3 Canada
      • 10.2.3.1 Canada market estimates and forecast, 2014 - 2025
  • 10.3 Europe
    • 10.3.1 Europe market estimates and forecast, 2014 - 2025
    • 10.3.2 Germany
    • 10.3.3 Germany market estimates and forecast, 2014 - 2025
    • 10.3.4 U.K.
    • 10.3.5 U.K. market estimates and forecast, 2014 - 2025
  • 10.4 Asia-Pacific
    • 10.4.1 Asia-Pacific market estimates and forecast, 2014 - 2025
    • 10.4.2 Japan
      • 10.4.2.1 Japan market estimates and forecast, 2014 - 2025
    • 10.4.3 China
      • 10.4.3.1 China market estimates and forecast, 2014 - 2025
    • 10.4.4 India
      • 10.4.4.1 India market estimates and forecast, 2014 - 2025
  • 10.5 Latin America
    • 10.5.1 Latin America market estimates and forecast, 2014 - 2025
    • 10.5.2 Brazil
      • 10.5.2.1 Brazil market estimates and forecast, 2014 - 2025
    • 10.5.3 Mexico
      • 10.5.3.1 Market estimates and forecast, 2014 - 2025
  • 10.6 Middle East and Africa
    • 10.6.1 Middle-East and Africa market estimates and forecast, 2014 - 2025
    • 10.6.2 South Africa
    • 10.6.3 South Africa market estimates and forecast, 2014 - 2025

Chapter 11 Company Profiles

  • 11.1 Company Profiles
    • 11.1.1 GlaxoSmithkline plc.
      • 11.1.1.1 Company overview
      • 11.1.1.2 Financial Performance
      • 11.1.1.3 Product benchmarking
      • 11.1.1.4 Strategic initiatives
    • 11.1.2 AstraZeneca
      • 11.1.2.1 Company overview
      • 11.1.2.2 Financial performance
      • 11.1.2.3 Product benchmarking
      • 11.1.2.4 Strategic initiatives
    • 11.1.3 Pfizer, Inc.
      • 11.1.3.1 Company overview
      • 11.1.3.2 Financial performance
      • 11.1.3.3 Product benchmarking
    • 11.1.4 OptiNose
      • 11.1.4.1 Company overview
      • 11.1.4.2 Product benchmarking
      • 11.1.4.3 Strategic initiatives
    • 11.1.5 Becton, Dickson and Company
      • 11.1.5.1 Company overview
      • 11.1.5.2 FINANCIAL PERFORMANCE
      • 11.1.5.3 Product benchmarking
    • 11.1.6 Promius Pharma
      • 11.1.6.1 Company overview
      • 11.1.6.2 FINANCIAL PERFORMANCE
      • 11.1.6.3 Product Benchmarking
      • 11.1.6.4 strategic initiatives
    • 11.1.7 B.F. Ascher & Company, Inc.
      • 11.1.7.1 Company overview
      • 11.1.7.2 Product benchmarking
    • 11.1.8 Cadila Pharmaceuticals
      • 11.1.8.1 Company overview
      • 11.1.8.2 Financial performance
      • 11.1.8.3 Product Benchmarking
    • 11.1.9 Douglas NZ
      • 11.1.9.1 Company overview
      • 11.1.9.2 Product benchmarking
    • 11.1.10 ENT Technologies Pty. Ltd.
      • 11.1.10.1 Company Overview
      • 11.1.10.2 Product Benchmarking
    • 11.1.11 Pendopharm
      • 11.1.11.1 Company Overview
      • 11.1.11.2 Product Benchmarking
    • 11.1.12 NAVEH Pharma
      • 11.1.12.1 Company Overview
      • 11.1.12.2 Product Benchmarking
Back to Top
전화 문의
F A Q